In contrast, CD4+ Th2 cells, regulatory B cells, CD4+ regulatory T cells (Tregs), myeloid-derived suppressor cells, and alternatively activated macrophages (M2) are pro-cancer immune cells [3]. This evidence concerns the gene CD4 and cancer.